Grifols | GRFS - Resultado Líquido





Resultado Líquido Alterar Data
Alaunos Therapeutics USD -1.16M 108K 2025-09
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD 24.56M 50.3M 2025-12
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cara Therapeutics USD -5.53M 621K 2025-09
Esperion Therapeutics USD 61.83M 93.16M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Immunic USD -24.37M 2.99M 2024-09
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
TherapeuticsMD USD -1.09M 356K 2024-06